These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8470282)
1. Inhibition of graft arteriosclerosis by modulation of the inflammatory response. Adams DH; Wyner LR; Steinbeck MJ; Karnovsky MJ Transplant Proc; 1993 Apr; 25(2):2092-4. PubMed ID: 8470282 [No Abstract] [Full Text] [Related]
2. Cardiac graft arteriosclerosis in the rat. Adams DH; Wyner LR; Karnovsky MJ Transplant Proc; 1993 Apr; 25(2):2071-3. PubMed ID: 8470275 [No Abstract] [Full Text] [Related]
3. Role of ICAM-1 in chronic rejection in the rat heart transplantation model. Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899 [No Abstract] [Full Text] [Related]
4. Altered expression of smooth muscle and non-muscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis. Suzuki J; Aikawa M; Isobe M; Sekiguchi M; Yazaki Y; Nagai R Transplant Proc; 1995 Feb; 27(1):578. PubMed ID: 7879106 [No Abstract] [Full Text] [Related]
5. Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat. Paul LC; Davidoff A; Benediktsson H Transplant Proc; 1994 Oct; 26(5):2873-4. PubMed ID: 7940907 [No Abstract] [Full Text] [Related]
6. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat. Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264 [No Abstract] [Full Text] [Related]
7. Spectrum of susceptibility to rejection of heart and multivisceral small bowel allografts using leflunomide immunosuppression. D'Silva M; DeRoover A; Nishimura Y; Antoniou E; Candinas D; Hubscher SG; McMaster P Transplant Proc; 1996 Apr; 28(2):948-9. PubMed ID: 8623475 [No Abstract] [Full Text] [Related]
8. The failure of donor essential fatty acid deficiency to prevent renal allograft rejection in rats. Lawen JG; Yu W; Cook HW; Wright JR Transplantation; 1993 Nov; 56(5):1269-70. PubMed ID: 8249137 [No Abstract] [Full Text] [Related]
9. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. Meiser BM; Wenke K; Thiery J; Wolf S; Devens C; Seidel D; Hammer C; Billingham ME; Reichart B Transplant Proc; 1993 Apr; 25(2):2077-9. PubMed ID: 7682363 [No Abstract] [Full Text] [Related]
11. Long-term n-3 polyunsaturated fatty acids administration ameliorates arteriosclerosis by modulating T-cell activity in a rat model of small intestine transplantation. Wang J; Ma H; Wang J; Li Q; Li Y; Li J Clin Chim Acta; 2007 Jun; 381(2):124-30. PubMed ID: 17395171 [TBL] [Abstract][Full Text] [Related]
12. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348 [No Abstract] [Full Text] [Related]
13. Effect of hemodynamics on graft rejection in the heterotopic heart transplantation model. Lange V; Gassel AM; Deuse T; Ulrichs K; Silber RE Transplant Proc; 1998 Jun; 30(4):1014-6. PubMed ID: 9636410 [No Abstract] [Full Text] [Related]
14. Macrophages and transplant arteriosclerosis: known and novel molecules. Russell ME J Heart Lung Transplant; 1995; 14(6 Pt 2):S111-5. PubMed ID: 8719472 [No Abstract] [Full Text] [Related]
15. Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model. Russell ME; Hancock WW; Wallace AF; Wyner LR; Karnovsky MJ Transplant Proc; 1995 Jun; 27(3):2100-4. PubMed ID: 7792898 [No Abstract] [Full Text] [Related]
16. FK 506 inhibits the development of transplant arteriosclerosis. Wu GD; Cramer DV; Chapman FA; Cajulis E; Wang HK; Starzl TE; Makowka L Transplant Proc; 1991 Dec; 23(6):3272-4. PubMed ID: 1721433 [No Abstract] [Full Text] [Related]
17. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously. Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286 [No Abstract] [Full Text] [Related]
18. Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. Silber RE; Lange V; Gassel AM; Ulrichs K Transplant Proc; 1998 Jun; 30(4):987-8. PubMed ID: 9636398 [No Abstract] [Full Text] [Related]
19. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection. Szabó G; Bährle S; Sivanandam V; Stumpf N; Gerö D; Berger I; Beller C; Hagl S; Szabó C; Dengler TJ J Heart Lung Transplant; 2006 Jul; 25(7):794-804. PubMed ID: 16818122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]